Company registration number 15257746 (England and Wales)
ANAVO CARE SCOT LTD
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2025
ANAVO CARE SCOT LTD
COMPANY INFORMATION
Directors
Mr James Oliver Braganza
(Appointed 3 November 2023)
Mr Thomas Allan Brookes
(Appointed 3 November 2023)
Mr Edward Guy Moore
(Appointed 3 November 2023)
Company number
15257746
Registered office
First Floor
15-17 The Crescent
Leatherhead
Surrey
KT22 8DY
Auditor
Arnold Hill & Co LLP
Sixth Floor
Capital Tower
91 Waterloo Road
London
SE1 8RT
ANAVO CARE SCOT LTD
CONTENTS
Page
Directors' report
1 - 2
Directors' responsibilities statement
3
Independent auditor's report
4 - 7
Profit and loss account
8
Statement of comprehensive income
9
Balance sheet
10
Statement of changes in equity
11
Notes to the financial statements
12 - 20
ANAVO CARE SCOT LTD
DIRECTORS' REPORT
FOR THE PERIOD ENDED 31 MARCH 2025
- 1 -

The directors present their annual report and financial statements for the period ended 31 March 2025.

Principal activities

The principal activity of the company is that to be of investment holding company.

Results and dividends

The results for the period are set out on page 8.

No ordinary dividends were paid. The directors do not recommend payment of a final dividend.

Directors

The directors who held office during the period and up to the date of signature of the financial statements were as follows:

Mr James Oliver Braganza
(Appointed 3 November 2023)
Mr Thomas Allan Brookes
(Appointed 3 November 2023)
Mr Edward Guy Moore
(Appointed 3 November 2023)
Financial instruments

The company's financial instruments comprise principally bank balances, bank loan and amounts due to group undertakings. The main purpose of these financial instruments is to raise funds for the company's operations and to finance the company's operations. The main risks arising from the company's financial instruments are interest rate risk, liquidity risk and credit risk. The directors review and agree policies for managing each of these risks and they are summarised below. These policies have remained unchanged throughout the year.

The company is exposed to fair value interest rate risk on its fixed rate borrowings and cash flow interest rate risk on floating rate deposits, bank overdrafts and loans. The company uses interest rate derivatives to manage the mix of fixed and variable rate debt so as to reduce its exposure to changes in interest rates.

The company is exposed to fair value interest rate risk on its fixed rate borrowings and cash flow interest rate risk on floating rate deposits, bank overdrafts and loans. The company uses interest rate derivatives to manage the mix of fixed and variable rate debt so as to reduce its exposure to changes in interest rates.

Investments of cash surpluses, borrowings and derivative instruments are made through banks and companies which must fulfil credit rating criteria approved by the Board.

 

All customers who wish to trade on credit terms are subject to credit verification procedures. Trade debtors are monitored on an ongoing basis and provision is made for doubtful debts where necessary.

Auditor

Arnold Hill & Co LLP were appointed as auditor to the company and in accordance with section 485 of the Companies Act 2006, a resolution proposing that they be re-appointed will be put at a General Meeting.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

Strategic report

The company directors have opted to apply the exemptions allowed under Section 414B of the Companies Act 2006 to not prepare a Strategic Report.

ANAVO CARE SCOT LTD
DIRECTORS' REPORT (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2025
- 2 -
On behalf of the board
Mr James Oliver Braganza
Director
3 November 2025
ANAVO CARE SCOT LTD
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE PERIOD ENDED 31 MARCH 2025
- 3 -

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

In preparing these financial statements, the directors are required to:

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

ANAVO CARE SCOT LTD
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF ANAVO CARE SCOT LTD
- 4 -
Opinion

We have audited the financial statements of Anavo Care Scot Ltd (the 'company') for the period ended 31 March 2025 which comprise the profit and loss account, the statement of comprehensive income, the balance sheet, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

ANAVO CARE SCOT LTD
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF ANAVO CARE SCOT LTD (CONTINUED)
- 5 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the directors' report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

 

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

ANAVO CARE SCOT LTD
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF ANAVO CARE SCOT LTD (CONTINUED)
- 6 -

Extent to which the audit was considered capable of detecting irregularities, including fraud

The objectives of our audit, in respect to fraud, are: to identify and assess the risks of material misstatement of the financial statements due to fraud; to obtain sufficient appropriate audit evidence regarding the assessed risks of material misstatement due to fraud, through designing and implementing appropriate responses; and to respond appropriately to fraud or suspected fraud identified during the audit. However, the primary responsibility for the prevention and detection of fraud rests with both those charged with governance of the entity and its management.

 

Our approach was as follows:

 

 

 

 

 

 

No instances of material non-compliance were identified. However, the likelihood of detecting irregularities, including fraud, is limited by the inherent difficulty in detecting irregularities, the effectiveness of the entity's controls, and the nature, timing and extent of the audit procedures performed. Irregularities that result from fraud might be inherently more difficult to detect than irregularities that result from error. As explained above, there is an unavoidable risk that material misstatements may not be detected, even though the audit has been planned and performed in accordance with ISAs (UK).

 

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

 

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

ANAVO CARE SCOT LTD
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF ANAVO CARE SCOT LTD (CONTINUED)
- 7 -

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Bobby Gurdep Bhogal ACA ACCA ATT (Senior Statutory Auditor)
For and on behalf of Arnold Hill & Co LLP, Statutory Auditor
Chartered Accountants
Sixth Floor
Capital Tower
91 Waterloo Road
London
SE1 8RT
3 November 2025
ANAVO CARE SCOT LTD
PROFIT AND LOSS ACCOUNT
FOR THE PERIOD ENDED 31 MARCH 2025
- 8 -
Period
ended
31 March
2025
Notes
£
Turnover
-
Administrative expenses
(5,000)
Operating loss
3
(5,000)
Interest payable and similar expenses
5
(788,941)
Loss before taxation
(793,941)
Tax on loss
6
-
0
Loss for the financial period
(793,941)

The profit and loss account has been prepared on the basis that all operations are continuing operations.

ANAVO CARE SCOT LTD
STATEMENT OF COMPREHENSIVE INCOME
FOR THE PERIOD ENDED 31 MARCH 2025
- 9 -
Period
ended
31 March
2025
£
Loss for the period
(793,941)
Other comprehensive income
-
Total comprehensive income for the period
(793,941)
ANAVO CARE SCOT LTD
BALANCE SHEET
AS AT 31 MARCH 2025
31 March 2025
- 10 -
2025
Notes
£
£
Fixed assets
Investments
7
14,170,269
Current assets
Debtors
9
100
Cash at bank and in hand
591,576
591,676
Creditors: amounts falling due within one year
10
(2,721,786)
Net current liabilities
(2,130,110)
Total assets less current liabilities
12,040,159
Creditors: amounts falling due after more than one year
11
(12,834,000)
Net liabilities
(793,841)
Capital and reserves
Called up share capital
13
100
Profit and loss reserves
14
(793,941)
Total equity
(793,841)

These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.

The financial statements were approved by the board of directors and authorised for issue on 3 November 2025 and are signed on its behalf by:
Mr James Oliver Braganza
Director
Company registration number 15257746 (England and Wales)
ANAVO CARE SCOT LTD
STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD ENDED 31 MARCH 2025
- 11 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Period ended 31 March 2025:
Loss and total comprehensive income
-
(793,941)
(793,941)
Issue of share capital
13
100
-
100
Balance at 31 March 2025
100
(793,941)
(793,841)
ANAVO CARE SCOT LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2025
- 12 -
1
Accounting policies
Company information

Anavo Care Scot Ltd is a private company limited by shares incorporated in England and Wales. The registered office is First Floor, 15-17 The Crescent, Leatherhead, Surrey, KT22 8DY.

1.1
Reporting period

The current reporting period runs from 3rd November 2023 to 31st March 2025 being the first accounting period since the company was incorporation.

1.2
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:

 

 

The financial statements of the company are consolidated in the financial statements of Anavo Capital Ltd. These consolidated financial statements are available on Companies House.

The company has taken advantage of the exemption under section 400 of the Companies Act 2006 not to prepare consolidated accounts. The financial statements present information about the company as an individual entity and not about its group.

 

Anavo Care Scot Ltd is a wholly owned subsidiary of Anavo Capital Ltd and the results of Anavo Care Scot Ltd are included in the consolidated financial statements of Anavo Capital Ltd which are available on Companies House.

ANAVO CARE SCOT LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 13 -
1.3
Going concern

The directors have considered the appropriateness of the going concern basis in preparing the financial statements of the company for the period ending 31 March 2025. As at 31 March 2025 the company made a loss of £793,941 and had net liabilities of £793,841. The company's immediate parent undertaking, has agreed to provide continuing financial support to the company, for at least twelve months after the date of approval by the directors of the financial statements for the year ended 31 March 2025. To enable the company to meet its liabilities as they fall due and as such the directors believe that the company is well placed to manage its business risks successfully. Thus the directors continue to adopt the going concern basis in preparing the financial statements.true

 

1.4
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

 

Investments in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.5
Borrowing costs related to fixed assets

Borrowing costs directly attributable to the acquisition, construction or production of qualifying assets, which are assets that necessarily take a substantial period of time to get ready for their intended use or sale, are added to the cost of those assets, until such time as the assets are substantially ready for their intended use or sale.

Investment income earned on the temporary investment of specific borrowings pending their expenditure on qualifying assets is deducted from the borrowing costs eligible for capitalisation.

All other borrowing costs are recognised in profit or loss in the period in which they are incurred.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

ANAVO CARE SCOT LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 14 -
1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

ANAVO CARE SCOT LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 15 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.

 

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

ANAVO CARE SCOT LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 16 -
1.10
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Key sources of estimation uncertainty

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.

Investments in subsidiaries, associates and jointly controlled entities are initially measured at cost less any accumulated impairment losses. The directors measure this by reviewing profitably and completing internal valuations to consider any potential impairments.

3
Operating loss
2025
Operating loss for the period is stated after charging:
£
Fees payable to the company's auditor for the audit of the company's financial statements
3,000
4
Employees

The average monthly number of persons (including directors) employed by the company during the period was:

2025
Number
3
ANAVO CARE SCOT LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2025
- 17 -
5
Interest payable and similar expenses
2025
£
Interest on bank overdrafts and loans
788,941
6
Taxation

The actual charge for the period can be reconciled to the expected credit for the period based on the profit or loss and the standard rate of tax as follows:

2025
£
Loss before taxation
(793,941)
Expected tax credit based on the standard rate of corporation tax in the UK of 25.00%
(198,485)
Unutilised tax losses carried forward
198,485
Taxation charge for the period
-
7
Fixed asset investments
2025
Notes
£
Investments in subsidiaries
8
14,170,269
Movements in fixed asset investments
Shares in subsidiaries
£
Cost or valuation
At 3 November 2023
-
Additions
14,000,000
Stamp duty paid
70,010
Legal fees
100,259
At 31 March 2025
14,170,269
Carrying amount
At 31 March 2025
14,170,269
ANAVO CARE SCOT LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2025
- 18 -
8
Subsidiaries

Details of the company's subsidiaries at 31 March 2025 are as follows:

Name of undertaking
Registered office
Class of
% Held
shares held
Direct
SCCL Operations Ltd
First Floor, 15-17 The Crescent, Leatherhead, Surrey, England, KT22 8DY
Ordinary
100.00
BAM PropCo (Burnside Ltd)
First Floor, 15-17 The Crescent, Leatherhead, Surrey, England, KT22 8DY
Ordinary
100.00
BAM Propco (Spiers) Ltd
First Floor, 15-17 The Crescent, Leatherhead, Surrey, England, KT22 8DY
Ordinary
100.00
BAM Propco (Johnstone) Ltd
First Floor, 15-17 The Crescent, Leatherhead, Surrey, England, KT22 8DY
Ordinary
100.00
BAM Propco (Newark) Ltd
First Floor, 15-17 The Crescent, Leatherhead, Surrey, England, KT22 8DY
Ordinary
100.00
9
Debtors
2025
Amounts falling due within one year:
£
Amounts owed by group undertakings
100

Amounts due to group undertaking are interest free and repayable on demand.

10
Creditors: amounts falling due within one year
2025
Notes
£
Bank loans
12
660,000
Amounts owed to group undertakings
2,025,592
Accruals and deferred income
36,194
2,721,786

Amounts due to group undertaking are interest free and repayable on demand.

11
Creditors: amounts falling due after more than one year
2025
Notes
£
Bank loans and overdrafts
12
12,834,000
ANAVO CARE SCOT LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2025
- 19 -
12
Loans and overdrafts
2025
£
Bank loans
13,494,000
Payable within one year
660,000
Payable after one year
12,834,000

The long-term loans are secured by fixed charges at the SONIA interest rate basis of 0.5% per annum over 67 months on a principal amount,

13
Share capital
2025
2025
Ordinary share capital
Number
£
Issued and fully paid
Ordinary Share Capital of £1 each
100
100
14
Profit and loss reserves
2025
£
At the beginning of the period
-
0
Adjusted balance
-
0
Loss for the period
(793,941)
At the end of the period
(793,941)
ANAVO CARE SCOT LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2025
- 20 -
15
Related party transactions
Transactions with related parties

During the period the company entered into the following transactions with subsidiary undertakings and parent company:

 

The following amounts were outstanding at the reporting end date:

2025
Amounts due to related parties
£
SCCL Operations Ltd
1,925,333
Anavo Care Ltd
100,259

The following amounts were outstanding at the reporting end date:

2025
Amounts due from related parties
£
Anavo Capital Ltd
100
16
Ultimate controlling party

The ultimate controlling party and the largest group financial statement that consolidate this company is Anavo Capital Ltd. These group accounts are available on Companies House.

2025-03-312023-11-03falsefalsefalseCCH SoftwareCCH Accounts Production 2025.300Mr James Oliver BraganzaMr Thomas Allan BrookesMr Edward Guy Moore152577462023-11-032025-03-3115257746bus:Director12023-11-032025-03-3115257746bus:Director22023-11-032025-03-3115257746bus:Director32023-11-032025-03-3115257746bus:RegisteredOffice2023-11-032025-03-31152577462025-03-3115257746core:RetainedEarningsAccumulatedLosses2023-11-032025-03-3115257746core:CurrentFinancialInstruments2025-03-3115257746core:Non-currentFinancialInstruments2025-03-3115257746core:ShareCapital2025-03-3115257746core:RetainedEarningsAccumulatedLosses2025-03-3115257746core:ShareCapitalOrdinaryShareClass12025-03-3115257746core:RetainedEarningsAccumulatedLosses2023-11-0215257746core:ShareCapital2023-11-032025-03-3115257746core:UKTax2023-11-032025-03-3115257746bus:OrdinaryShareClass12023-11-032025-03-3115257746bus:OrdinaryShareClass12025-03-3115257746bus:PrivateLimitedCompanyLtd2023-11-032025-03-3115257746bus:FRS1022023-11-032025-03-3115257746bus:Audited2023-11-032025-03-3115257746bus:FullAccounts2023-11-032025-03-31xbrli:purexbrli:sharesiso4217:GBP